Table 3 Stratification According to Menopause: Comparison of Pathological Results Between HPV16/18/45 + and Other HR-HPV + Groups, n (%)
From: Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
Premenopausal group | Postmenopausal group | ||||||
|---|---|---|---|---|---|---|---|
HPV16/18/45+ (%) | Other HR-HPV+ (%) | HPV16/18/45+ (%) | Other HR-HPV+ (%) | ||||
Pathological results of cervical biopsy | LSIL- | 846(76.1) | 220(57.7) | 626(85.8) | 189(68.5) | 59(50.5) | 130(81.8) |
HSIL+ | 265(23.8) | 161(42.3) | 104(14.2) | 87(31.5) | 58(49.6) | 29(18.3) | |
Ca | 29(2.6) | 17(4.5) | 12(1.6) | 35(12.7) | 26(22.2) | 9(5.7) | |
1111 | 381(34.3) | 730(65.7) | 276 | 117(42.4) | 159(57.6) | ||
χ2 value | 113.439 | 32.114 | |||||
P value | < 0.001 | < 0.001 | |||||